Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Neostigmine and Glycopyrrolate for Bowel Evacuation in SCI
NCT00855283Phase 2Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Sep 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of neostigmine in neurogenic bowel (NBD), sponsored by United States Department of Veterans Affairs. Primary endpoint: Bowel evacuation. Started Sep 2012; status: completed.
02
Drugs
neostigmine
03
Conditions
neurogenic bowel (NBD)
Beyond the preview
Go deeper on NCT00855283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855283.